Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions episode artwork

EPISODE · May 5, 2021 · 42 MIN

Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions

from Keeping Current CME

An oncologist and an endocrinologist discuss recent developments in NTRK fusion thyroid cancer, including epidemiology, testing, and treatment options. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/950453?src=mkm_podcast_addon_950453

Episode metadata supplied by the publisher feed · Published May 5, 2021

Embed this episode

NOW PLAYING

Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions

0:00 42:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 42 minutes long.

When was this Keeping Current CME episode published?

This episode was published on May 5, 2021.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!